Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine nasal spray in Chinese patients with depression and acute suicidal ideation or behavior
CTR20250504Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2025
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of Keyzilen in major depressive disorder (MDD), sponsored by Janssen Pharmaceutical. Started Mar 2025; status: completed.
02
Drugs
Keyzilen
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20250504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250504.